These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33720393)

  • 1. How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis.
    Bai K; Allen C
    Laryngoscope; 2021 Sep; 131(9):2041-2047. PubMed ID: 33720393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
    Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
    Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
    Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
    J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
    Pawlita M; Gissmann L
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S100-2. PubMed ID: 19353471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
    Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
    JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research status of human papillomavirus vaccine for prevention and treatment of respiratory papillomatosis].
    Pan XF; Wang J; Xiao Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):189-192. PubMed ID: 30808153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
    Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
    JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
    Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
    J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perspectives on recurrent respiratory papillomatosis and human papillomavirus].
    Trolle S; Lynggaard CD; Gregersen KG; Baandrup L; Grønhøj C; Buchwald CV
    Ugeskr Laeger; 2019 Oct; 181(41):. PubMed ID: 31610833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
    Sullivan C; Curtis S; Mouzakes J
    Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
    Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
    J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP).
    Israr M; DeVoti JA; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Front Immunol; 2020; 11():336. PubMed ID: 32210959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
    Jackowska J; Piersiala K; Klimza H; Wierzbicka M
    Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice.
    Ahn J; Peng S; Hung CF; Roden RBS; Best SR
    Laryngoscope; 2018 Jan; 128(1):E16-E20. PubMed ID: 28868617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
    Bonagura VR; Hatam LJ; Rosenthal DW; de Voti JA; Lam F; Steinberg BM; Abramson AL
    APMIS; 2010 Jun; 118(6-7):455-70. PubMed ID: 20553528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress in the adjunct therapy of recurrent respiratory papillomatosis].
    Shen M; Xiao Y; Ma L; Wang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 34(12):1145-1148. PubMed ID: 33254355
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on Recurrent Respiratory Papillomatosis.
    Derkay CS; Bluher AE
    Otolaryngol Clin North Am; 2019 Aug; 52(4):669-679. PubMed ID: 31078306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
    Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
    Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for HPV Malignancies.
    Lee MY; Allen CT
    Semin Radiat Oncol; 2021 Oct; 31(4):361-370. PubMed ID: 34455991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses.
    Song YC; Huang HC; Chang CY; Lee HJ; Liu CT; Lo HY; Ho TY; Lin WC; Yen HR
    Front Immunol; 2020; 11():62. PubMed ID: 32153559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.